Asian Spectator

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

  • Written by ACN Newswire - Press Releases

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

SHANGHAI, CHINA, Jul 20, 2020 - (ACN Newswire) - Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and best-in-class therapies, today announced that it has successfully closed US$97 million in Series C financing.

The...

Magazine

Pemenang Nobel Kedokteran 2024: duo penemu RNA-mikro, molekul yang kendalikan gen kita

Ilustrasi duo penemu RNA-mikro, Victor Ambros and Gary Ruvkun yang menangkan Nobel Kedokteran 2024. Ill. Niklas Elmehed/Nobel Prize OutreachDua ilmuwan asal Amerika Serikat (AS), Victor Ambros (UMASS ...

Konflik Nikita Mirzani dan putrinya: momen refleksi efektivitas kebijakan perlindungan anak di Indonesia

Poomstock/ShutterstockBeberapa waktu lalu, konflik rumah tangga yang terjadi antara selebritas Nikita Mirzani dengan anak perempuannya, inisial LM, menyita perhatian warganet di media sosial dan menja...

Pornografi ‘deepfake’: mengapa membuatnya—bukan hanya menyebarkannya—merupakan kejahatan

icsnaps/ShutterstockPornografi deepfake—ketika kemiripan seseorang dipaksakan ke dalam gambar eksplisit seksual dengan kecerdasan buatan—sangat umum terjadi. Situs web paling populer yang ...



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion